Primary Extra-Adrenal Pheochromocytoma Positive I-123 MIBG Imaging with Negative I-131 MIBG Imaging
- 1 December 1986
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 11 (12) , 851-854
- https://doi.org/10.1097/00003072-198612000-00012
Abstract
I-131 metaiodobenzylguanidine (I-131 MIBG) is a well established imaging agent that reliably detects pheochromocytoma. In some patients, however, I-131 MIBG may fail to localize pheochromocytoma. I-123 MIBG has several potential advantages over I-131 MIBG, and these advantages may enable locating pheochromocytomas which have eluded other techniques, including I-131 MIBG imaging. A patient with primary extraadrenal pheochromocytoma is described who illustrates the superiority of I-123 MIBG for the imaging of pheochromocytoma.This publication has 8 references indexed in Scilit:
- Comparison of Iodobenzylguanidine Imaging with Computed Tomography in Locating Pheochromocytoma*Journal of Clinical Endocrinology & Metabolism, 1985
- Pheochromocytoma and the normal adrenal medulla: improved visualization with I-123 MIBG scintigraphy.Radiology, 1985
- MR Imaging of PheochromocytomasJournal of Computer Assisted Tomography, 1985
- I-131 METAIODOBENZYLGUANIDINE FOR THE LOCATING OF SUSPECTED PHEOCHROMOCYTOMA - EXPERIENCE IN 400 CASES1985
- SALIVARY-GLAND ACCUMULATION OF META-[I-131]IODOBENZYLGUANIDINE1984
- PORTRAYAL OF PHEOCHROMOCYTOMA AND NORMAL HUMAN ADRENAL-MEDULLA BY META-[I-123]IODOBENZYLGUANIDINE - CONCISE COMMUNICATION1984
- Complementary roles of CT and 131I-MIBG scintigraphy in diagnosing pheochromocytomaAmerican Journal of Roentgenology, 1983
- Scintigraphic Localization of PheochromocytomaNew England Journal of Medicine, 1981